• sibutramine
  • Since discontinued to its potential for causing valvulopathies and pulmonary hypertension) Lorcaserin Mazindol Mefenorex Phentermine Sibutramine† (in some countries withdrawn from the market because of concerns regarding its cardiovascular effects) The following are listed as appetite depressants by MeSH, an index of medical journal articles and books. (wikipedia.org)
  • Ketamine
  • CCP, added by 2010 Regulations) 1-(3-Chlorophenyl)piperazine (i.e. mCPP, added by 2010 Regulations) Chlorphentermine Diethylpropion Ethchlorvnol (presumably Ethchlorvynol) Ethinamate Flunitrazepam (moved up from Schedule 4 by 1993 Regulations) 4-Hydroxybutanoic acid (added by 1993 Regulations) Ketamine (added by 2010 Regulations) Mazindol Mephentermine Meprobamate Methyprylone Pemoline Pentazocine Phentermine Pipradrol Temazepam (moved up from Schedule 4 by 1993 Regulations) Controlled medicinal products (and certain derivatives thereof). (wikipedia.org)
  • Temazepam
  • Stimulants (mostly anorectics) Amfepramone Aminorex Clobenzorex Ethylamphetamine Fencamfamine Fenproporex Lefetamine Mefenorex Mazindol Pemoline Pipradrol Propylhexedrine Pyrovalerone All benzodiazepines (including temazepam, but not including flunitrazepam) Barbiturates Allobarbital Barbital Butobarbital Methylphenobarbital Phenobarbital Secbutabarbital Vinylbital Other sedative-hypnotics Ethchlorvynol Ethinamate Methyprylon Zolpidem Meprobamate Mesocarb Tables V and VI comprise precursor substances (and salts thereof) which may be used to manufacture drugs listed under Tables I and II. (wikipedia.org)
  • treatment
  • Mazindol is used in short-term (i.e., a few weeks) treatment of obesity, in combination with a regimen of weight reduction based on caloric restriction, exercise, and behavior modification in people with a body mass index of greater than 30, or in those with a body mass index of more than 27 in the presence of risk factors such as hypertension, diabetes, or hyperlipidemia. (wikipedia.org)